Delivery Order SPE2DB22D1041-SPE2DB25FTZM6

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a firm fixed price of $33,154.85 and a period of performance through January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, one of the largest pharmaceutical distributors in the United States. The contract is for the delivery of Rifampin 300 mg capsules, a critical antibiotic medication, with a ceiling value of $2,148.60 and a completion date of September 25, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Rifampin 300 mg capsules. The contract is valued at $3,894.85 and has a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.92 firm fixed-price delivery order is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $5,497.73 and a period of performance through January 5, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. This contract is not designated as a set-aside. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,666.56, is a firm fixed-price delivery order for 4,567,237,200 units of the medication rifampin 300 mg capsules. The contract has a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The contract has a total ceiling value of $3,859.14 and is set to run until September 5, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, enabling them to efficiently provide a wide range of pharmaceutical and medical products to support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $7,270.07, is for the delivery of RIFAMPIN 300 MG CAPSULE 60S to the Defense Logistics Agency (DLA). The contract, awarded as a Delivery Order under Firm Fixed Price terms, has a completion date of June 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of RIFAMPIN 300 MG CAPSULE 60S. The contract has an award value of $28,715.33 and a period of performance through February 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rifampin 300 mg capsules. The contract has an ultimate completion date of July 18, 2024 and a ceiling value of $4,642.08. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZM6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $37,446.85 and a period of performance through February 11, 2025. This is not a set-aside contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/12/25, 9:56 AM